ALX Oncology CMO Sophia Randolph resigns; separation includes $503,880 and accelerated vesting

ALX ONCOLOGY HOLDINGS INC

CMO Sophia Randolph resigns effective Oct 11, 2024; she leaves to pursue other professional opportunities.
Separation agreement includes $503,880 lump sum payment plus COBRA coverage for up to 18 months.
Outstanding stock options and RSUs that would vest in 12 months post-separation will fully vest; options exercisable until July 11, 2026.
Company will commence a search for a new Chief Medical Officer.
She will provide transition consulting services via a consulting agreement for up to 18 months.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Sophia Randolph

Chief Medical Officer

ALXO · ALX ONCOLOGY HOLDINGS INC

Effective: 2024-10-11
Filed: October 4, 2024, 7:59 PM ET

On September 30, 2024, Sophia Randolph, M.D., Ph.D., Chief Medical Officer of ALX Oncology Holdings Inc. (the “Company”) informed the Company of her resignation from her position effective October 11, 2024, to pursue other professional opportunities.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sophia Randolph resigned as Chief Medical Officer at ALX ONCOLOGY HOLDINGS INC.

Action: resigned
Role: Chief Medical Officer

Exact text from the filing

On September 30, 2024, Sophia Randolph, M.D., Ph.D., Chief Medical Officer of ALX Oncology Holdings Inc. (the “Company”) informed the Company of her resignation from her position effective October 11, 2024, to pursue other professional opportunities.

View on SEC.gov

ALX ONCOLOGY HOLDINGS INC filing history →

Source: SEC EDGAR

accession 0000950170-24-112734

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.